Oxidative stress in childhood - In health and disease states

Clinical Nutrition

Volumn 23, Issue 1, 2004, Pages 3-11

  Granot, Esther ^a   Kohen, Ron ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Antioxidants; Childhood; Oxidative stress

Indexed keywords

2,4 DINITROPHENYLHYDRAZINE; ACETYLCYSTEINE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CARBONYL DERIVATIVE; CARNOSINE; CAROTENE; CATALASE; CYCLOSPORIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; HYDROGEN PEROXIDE; LIPID; MALONALDEHYDE; PEROXIDASE; POLYPHENOL; POLYUNSATURATED FATTY ACID; PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SUPEROXIDE DISMUTASE; TACROLIMUS; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOCTIC ACID; TOCOPHEROL; UBIDECARENONE; UNINDEXED DRUG; URIC ACID; XANTHINE OXIDASE;

BLOOD ANALYSIS; CHILD; CHILD GROWTH; CHILD HEALTH; CHILDHOOD DISEASE; CYCLIC POTENTIOMETRY; DIET SUPPLEMENTATION; DIETARY INTAKE; HUMAN; INFANT DISEASE; LABORATORY TEST; LIPID OXIDATION; MATURATION; MEASUREMENT; METHODOLOGY; MOLECULAR MECHANICS; MOLECULAR WEIGHT; NEPHROTOXICITY; NEUROTOXICITY; OXIDATION; OXIDATIVE STRESS; PROTEIN METABOLISM; REVIEW;

EID: 1242297083     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0261-5614(03)00097-9     Document Type: Review

References (78)

1. Halliwell B, Gutteridge JMC. Free radical in biology and medicine. Oxford: Clarendon Press, Oxford University Press; 2000. p.160-5.
2. Menzal DB. The toxicity of air pollution in experimental animals and humans: the role of oxidative stress. Toxicol Lett 1994;72:269-77.
3. Podda M, Traber MG, Weber C, Yan LJ, Pakcer L. UV-irradiation depletes antioxidants and causes damage in a model of human skin. Free Rad Biol Med 1998;92:5258-65.
4. Deliconstantinos G, Villicotov V, Stavrides JC. Alteration of nitric oxide synthase and xanthine oxidase activates of human keratinocytes by ultraviolet B radiation. Potential role for peroxynitrite in skin inflammation. Biochem Pharmacol 1996;51:1727-38.
5. Ginsburg I, Kohen R. Cell damage in inflammatory and infectious sites might involve a coordinated 'cross-talk' among oxidants, microbial haemolysins and ampiphiles, cationic proteins, phospholipases, fatty acids, proteinases and cytokines (an overview). Free Rad Res 1995;22:489-517.
6. Adelman R, Saul RL, Ames BN. Oxidative damage to DNA: relation to species metabolic rate and life span. Proc Natl Acad Sci USA 1988;85:2706-8.
7. Karten B, Beisiegel U, Gercken G, Konstusk A. Mechanism of lipid peroxidation in human blood plasma: a kinetic approach. Chem Phys Lipid 1988;88:83-96.
8. Kohen R. Skin antioxidants: their role in aging and in oxidative stress - new approaches for their evaluation. Biomed Pharmaceother 1999;53:181-92.
9. Sies H. Oxidative stress: oxidant and antioxidant. Exp Physiol 1997;82:291-5.
10. Rice-Evans M, Miller NJ. Total antioxidant status in plasma and body fluid. Method Enzymol 1994;234:279-93.
11. Draper HH, Squires E, Mahmood H, Wu J, Agarwal S, Hadley M. A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Rad Biol Med 1993;15:353-63.
12. Chirico S. High performance liquid chromatography-based thiobarbituric acid tests. Methods Enzymol 1994;233:314-8.
13. Frank H, Hintze T, Bimboes D, Remmer H. Monitoring lipid peroxidation by breath analysis. Endogenous hydrocarbons and their metabolic elimination. Toxicol Appl Pharmacol 1980;56:337-44.
14. Springfield JR, Levitt MD. Pitfalls in the use of breath pentane measurements to assess lipid peroxidation. J Lipid Res 1994;35:1497-504.
15. Esterbauer J, Jürgens G, Queenberger O, Koller A. Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin e and generation of aldehydes. J Lipid Res 1987;28:495-509.
16. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modification of low density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320:915-24.
17. Kontush A, Beisiegel U. Measurement of oxidizability of blood plasma. Methods Enzymol 1999;299:35-49.
18. Stadtman ER, Oliver CN. Metal catalyzed oxidation of proteins: physiological consequence. J Biol Chem 1991; 266:2005-8.
19. Reznick AZ, Packer L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 1994;233:357-63.
20. Kohen R, Beit-Yannai E, Berry EM, Tirosh O. Overall low molecular weight antioxidant activity of biological fluids and tissues by cyclic voltammetry. Methods Enzymol 1994; 300:285-96.
21. Harris ML, Schiller JH, Reilly PM, Donovitz M, Grisham MB, Bulkley GB. Free radicals and other reactive oxygen metabolites in inflammatory bowel disease. Pharmacol Ther 1992;53:375-408.
22. Kohen R, Fauberstein D, Tirosh O. Reducing equivalents in the aging process. Arch Gerontol Geriatr 1997;24: 103-23.
23. Jacques PF, Cylack LT, McGandy RB, Hartz SC. Antioxidant status in persons with and without senile cataract. Arch Ophthalmol 1988;106:337-40.
24. Harats D, Ben-Naim M, Dabach Y, et al. Effect of vitamin D and E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking. Atherosclerosis 1990;85:47-54.
25. Schwartz KB. Oxidative stress during viral infection: a review. Free Rad Biol Med 1996;21:641-9.
26. Powell CVE, Nash AA, Powers HJ, Primhak RA. Antioxidant status in asthma. Pediatr Pulmonol 1994;18:34-8.
27. Haklar G, Vegenaga I, Yalcin AS. Evaluation of oxidant stress in chronic hemodialysis patients: use of different parameters. Clin Chim Acta 1995;234:109-14.
28. Stone WL, Papas AM. Tocopherols and the etiology of colon cancer. J Natl Cancer Inst 1997;89:1006-14.
29. Cooke RWI. Factors associated with chronic lung disease in preterm infants. Arch Dis Child 1991;66:776-9.
30. Kjellmer I. Mechanisms of perinatal brain damage. Ann Med 1991;23:675-9.
31. Sigurdsson L, Reyes J, Kocoshis SA, Hansen TW, Rosh J, Knisely AS. Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies. J Pediatr Gast Nutr 1998;26:85-9.
32. Babin F, Lemonnier F, Goguelin A, Alagille D, Lemonnier A. Plasma fatty acid composition and lipid peroxide levels in children with paucity of interlobular bile ducts. Ann Nutr Metab 1988;32:220-30.
33. Portal B, Richard MJ, Coudray C, Arnaud J, Favier A. Effect of double-blind cross-over selenium supplementation on lipid peroxidation markers in cystic fibrosis patients. Clin Chim Acta 1995;234:137-46.
34. Golden MHN, Ramdath D. Free radicals in the pathogenesis of kwashiorkor. Proc Nutr Soc 1987;46:53-68.
35. Sklodowska M, Gromadzinska J, Biernacka M, et al. Vitamin E, thiobarbituric acid reactive substance concentrations and superoxide dismutase activity in the blood of children with juvenile rheumatoid arthritis. Clin Exp Rheumatol 1996; 14:433-9.
36. Treem WR, Sokol RJ. Disorders of mitochondria. Sem Liver Dis 1998;18:237-53.
37. Hammerman C, Goldschmidt D, Caplan MS, et al. Amelioration of ischemia reperfusion injury in rat intestine by pentoxifylline-mediated inhibition of xanthine oxidase. J Ped Gast Nutr 1999;29:69-74.
38. Mansouri A, Gaou I, Fromenty B, et al. Premature oxidative aging of hepatic mitochondrial DNA in Wilson's disease. Gastroenterology 1997;113:599-605.
39. Pitkanen S, Robinson B. Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase. J Clin Invest 1996; 98:345-51.
40. Swartz MN. Mitochondrial toxicity - new adverse drug effects. N Engl J Med 1995;333:1146-8.
41. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-4.
42. Weiss ST. Diet as a risk factor for asthma. Ciba Found Symp 1997;206:244-57.
43. Greene LS. Asthma, oxidant stress and diet. Nutrition 1999;15:899-907.
44. Khaled MA. Oxidative stress in childhood malnutrition and diarrheal disease. J Diarrheal Dis Res 1994;12:165-72.
45. Granot E, Binsztok M, Fraser D, Deckelbaum RJ, Weizman Z. Oxidative stress is not enhanced in non-malnourished infants with persistent diarrhea. J Trop Pediatr 2001;47:284-7.
46. Lindley KJ, Goss-Sampson MA, Muller DPR. Lipid peroxidation and electrogenic ion transport in the jejunum of the vitamin D deficient rat. Gut 1994;35:34-9.
47. Argenzio RA, Rhoads JM. Reactive oxygen metabolites in piglet cryptosporodiosis. Pediatr Res 1997;41:521-6.
48. Jovanovic SV, Clements D, MacLeod K. Biomarkers of oxidative stress are significantly elevated in Down's syndrome. Free Radic Biol Med 1998;25:1044-8.
49. Pastor MC, Sierra C, Dolade M, et al. Antioxidant enzymes and fatty acid status in erythrocytes of Down's syndrome patients. Clin Chem 1998;44:924-9.
50. Ludvigsson J. Intervention at diagnosis of type I diabetes using either antioxidants or photopheresis. Diab Metab Rev 1993;9:329-36.
51. Bean JP, Sy A. Vitamin E supplementation in Senegalese children with kwashirorkor. Sante 1996;6:209-12.
52. Beal MF. Coenzyme Q10 administration and its potential for treatment of neurodegenerative diseases. Biofactors 1999; 9:261-6.
53. Sue CM, Hirano M, DiMauro S, De-Vivo DC. Neonatal presentations of mitochondrial metabolic disorders. Semin Perinatol 1999;23:113-24.
54. Wolf A, Trendelenburg CF, Diez-Fernandez C, Prieto P. The role of oxidative stress in the in vitro hepatotoxicity of cyclosporine A. J Pharmacol Exp Ther 1997;280:1328-31.
55. Granot E, Shemesh P, Rivkin L, Kohen R. Plasma and L D L lipid peroxidation in cyclosporine treated post-liver transplant children. Transplant Proc 1998;30:4056-9.
56. Granot E, Elinav H, Kohen R. Markers of oxidative damage and antioxidant capacity in cyclosporine-treated and tacrolimus-treated children after liver transplantation. Liver Transplant 2002, in press.
57. Koletzko B, Bremer HJ. Fat content and fatty acid composition of infant formulas. Acta Pediatr Scand 1989; 78:512-3.
58. Dennery PA, Kramer CM, Alpert SE. Effect of fatty acid profiles on the susceptibility of cultured rabbit tracheal epithelial cells to hyperoxic injury. Am J Respir Cell Mol Biol 1990;3:137-44.
59. Shahar E, Folsom AR, Melnick SL, et al. Dietary n-3 polyunsaturated fatty acids and smoking-related chronic obstructive pulmonary disease. N Engl J Med 1994;331: 228-33.
60. Cooke RWI. Factors associated with chronic lung disease in preterm infants. Arch Dis Child 1991;66:776-9.
61. Hammerman C, Aramburo MJ. Decreased lipid intake reduces morbidity in sick premature neonates. J Pediatr 1988;113:1083-7.
62. Granot E, Golan D, Rivkin L, Kohen R. Oxidative stress in healthy breast-fed versus formula-fed infants. Nutrition Res 1999;19:869-80.
63. Khaira HS, Maxwell SR, Shearman CP. Antioxidant consumption during exercise in intermittent claudication. Br J Surg 1995;82:1660-2.
64. Vainio H. Chemoprevention of cancer lessons to be learned from beta-carotene trials. Toxicol Lett 2000;112-113: 513-7.
65. Leppala JM, Virtamo J, Fogelholm R, et al. Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers. Arterioscler Thromb Vasc Biol 2000;20:230-5.
66. Mailila N, Virtamo J, Virtanen M, Albanes D, Tangrea JA, Huttunen JK. The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers. Cancer Epidemiol Biomarkers Prev 1999;8:489-93.
67. Rautalahti MT, Virtamo JR, Taylor PR, et al. The effects of supplementation with alpha-tocopherol and beta-carotene on the incidence and mortality of carcinoma of the pancreas in a randomized, controlled trial. Cancer 1999;86:37-42.
68. Teikari JM, Laatikainen L, Virtamo J, et al. Six-year supplementation with alpha-tocopherol and beta-carotene and age-related maculopathy. Acta Ophthalmol Scand 1998; 76:224-9.
69. Pryor WA, Stahl W, Rock CL. Beta-carotene: from biochemistry to clinical trials. Nutr Rev 2000;58:39-53.
70. Wang XD, Russell RM. Procarcinogenic and anticarcinogenic effects of beta carotene. Nutr Rev 1999;57:263-72.
71. Brown BG, Zhao XQ, Chait A. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001;345:1583-92.
72. Cheung MC, Zhao QX, Chait A, Albers JJ, Brown BG. Antioxidant supplementations block the response kof HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL. Arterioscler Thromb Vasc Biol 2001;21:1320-6.
73. Krinsky NI, Beecher GR, Burk RF, Chan AC, Erdman JW, Jacob RA. Panel on Dietary Antioxidants and Related Compounds. Food and Nutrition Board, National Academy of Sciences, National Academy Press, 2000.
74. Kamat AM, Lamm DL. Chemoprevention of bladder cancer. Urol Clin North Am 2002;29:157-68.
75. Allen RG, Venkatraj VS. Oxidants and anti-oxidants in development and differentiation. J Nutr 1992;122: 631-5.
76. De Lamirande E, Gagnon C. Impact of reactive oxygen species on spermatozoa: a balancing act between beneficial and detrimental effects. Hum Reprod 1995;10(Suppl 1): 15-21.
77. Ramacle J, Raes M, Toussaint O, Renard P, Rao G. Low levels of reactive oxygen species as modulators of cell function. Mutat Res 1995;316:103-22.
78. Spitzer JA. Active oxygen intermediates - beneficial or deleterious? Proc Soc Exp Biol Med 1995;209:102-3.